WOOF · Petco Health & Wellness Company, Inc.
Market Cap
$853.66M
Shares
323.36M
WOOF metrics
73 of 114 screener metrics currently available.
Market overview
2 metricsShare price
$2.63
Market cap
$853.66M
Price action
19 metricsPrice change (1W)
-6.5%
Price change (30D)
-11.3%
Price change (3M)
-12.8%
Price change (6M)
-2.6%
Price change (YTD)
-8.2%
Price change (1Y)
-35.3%
Trailing year
Price change (5Y)
-88.4%
52-week high
$3.91
52-week low
$2.33
Change from 52-week high
-34.0%
Change from 52-week low
+10.7%
Annualized volatility
61.6%
Beta
0.9
RSI (14D)
39.8
Price vs SMA 50
-4.8%
Price vs SMA 200
-7.7%
Avg volume (3M)
1.91M
Relative volume
0.8
Average dollar volume
$5.24M
Company
3 metricsSector
Consumer Cyclical
Industry
Specialty Retail
Shares outstanding
323.36M
Valuation
12 metricsP / E (TTM)
129.0
Trailing earnings · reciprocal yield 0.8%
PEG ratio
—
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
0.1×
reciprocal yield 694.8%
P / book
0.7
reciprocal yield 134.6%
FCF yield
18.8%
TTM · current market cap
Buyback yield
—
P / FCF
5.3
reciprocal yield 18.8%
P / operating cash flow
2.9
reciprocal yield 34.8%
Earnings yield
0.7%
Historical valuation
8 metricsP / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
—
EV / revenue historical average (5Y)
—
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—
Dividends & buybacks
7 metricsDividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—
Earnings calendar
2 metricsNext earnings
2026-09-02
Last earnings
2026-06-03
Profitability
9 metricsGross margin
38.7%
Operating margin
2.2%
Trailing 12 months
Net margin
0.1%
Gross profit (TTM)
$2.31B
Operating profit (TTM)
$128.70M
Net income (TTM)
$5.58M
Trailing 12 months
Diluted EPS (TTM)
$0.02
FCF margin
2.7%
Effective tax rate
63.2%
Growth
11 metricsRevenue growth YoY
+0.2%
Year over year
Net income growth YoY
—
Revenue (TTM)
$5.96B
Trailing 12 months
EPS growth YoY
—
Shares change YoY
+2.2%
Year over year · more shares
Revenue CAGR (3Y)
-0.4%
Revenue CAGR (5Y)
+3.9%
EPS CAGR (3Y)
-55.5%
EPS CAGR (5Y)
—
FCF CAGR (3Y)
+40.1%
FCF CAGR (5Y)
+11.4%
Quality
14 metricsReturn on equity
0.5%
Return on assets
0.1%
Debt / equity
—
Current ratio
0.9
EBITDA (TTM)
$324.64M
Free cash flow (TTM)
$161.70M
Quick ratio
0.3
Interest coverage
1.0
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Cash & equivalents
$166.80M
Total assets
$5.08B
Total debt
$1.49B
Cash flow & spend
7 metricsOperating cash flow (TTM)
$298.54M
Capital expenditures (TTM)
$136.84M
R&D (TTM)
—
SG&A (TTM)
$2.18B
Stock compensation (TTM)
$32.68M
R&D / revenue
—
Stock compensation / revenue
0.5%
Ownership (13F)
3 metrics13F filers
197
13F filer change QoQ
-8
Institutional ownership
93.2%
Short interest
3 metricsShort interest
6.0%
Latest settlement · 13.0 days to cover
Days to cover
13.0d
Short-squeeze score
73 / 100
Insider activity
2 metricsNet insider buying (90D)
−$1.15M
Insider-sentiment score
32 / 100
Risk flags
1 metricsGoing concern
—
Key facts
CIK
1826470
CUSIP
71601V105
13F (30d)
160 filings
160 filers
Visit website
Investor relations